연구동향 분석

Original Article : Serum transferrin as Liver fibrosis biomarkerin patients with chronic hepatitis B

( Hyo Jung Cho ) ( Soon Sun Kim ) ( Seun Joo Ahn ) ( Joo Han Park ) ( Dong Joon Kim ) ( Young Bae Kim ) ( Sung Won Cho ) ( Jae Youn Cheong ) 2014년

논문상세정보
인용/피인용
' Original Article : Serum transferrin as Liver fibrosis biomarkerin patients with chronic hepatitis B' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • alpha-1 antitrypsin
  • chronic hepatitis b
  • liver cirrhosis
  • transferrin
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,874 0

0.0%

' Original Article : Serum transferrin as Liver fibrosis biomarkerin patients with chronic hepatitis B' 의 참고문헌

  • Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis
    Bassett ML Hepatology 6 : 24 ~ 29 - [1986]
  • Validation of the fibrotest biochemical markers score in assessing liver fibrosis in hepatitis C patients
    Rossi E Clin Chem 49 : 450 ~ 454 - [2003]
  • Transferrin metabolism in alcoholic liver disease
    Potter BJ Hepatology 5 : 714 ~ 721 - [1985]
  • The predictive value of fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C
    Le Calvez S Hepatology 39 : 862 ~ 863 [2004]
  • The parameters of collagen proteolytic and metabolic systems in chronic liver diseases of viral and toxic etiologies
    Beloborodova EV Ter Arkh 82 : 29 ~ 34 [2010]
  • The effect of iron depletion on chronic hepatitis C virus infection
    Franchini M Hepatol Int 2 : 335 ~ 340 - [2008]
  • The biology of transferrin
    de Jong G Clin Chim Acta 190 : 1 ~ 46 [1990]
  • Simple and rapid detection of liver cirrhosis in children by tracking serum IgA/transferrin ratio
    Ibrahim AM J Exp Integr Med (1) : 117 ~ 121 [2011]
  • Serum proteomic MRM identify peptide ions of transferrin as new fibrosis markers in chronic hepatitis B
    Xu MY Biomed Pharmacother 67 : 561 ~ 567 - [2013]
  • Serum markers for predicting significant necroinflammatory activity in patients with chronic hepatitis B
    Cho HJ Clin Biochem 45 : 1564 ~ 1567 - [2012]
  • Serum iron markers in patients with chronic hepatitis C infection
    Vagu C Hepat Mon 13 : e13136 ~ - [2013]
  • Sampling variability on percutaneous liver biopsy
    Abdi W Arch Intern Med 139 : 667 ~ 669 - [1979]
  • Sampling variability of liver fibrosis in chronic hepatitis C
    Bedossa P Hepatology 38 : 1449 ~ 1457 - [2003]
  • Revision and update on clinical practice guideline for liver cirrhosis
    Suk KT Korean J Hepatol 18 : 1 ~ 21 [2012]
  • Regulation of cellular iron metabolism
    Wang J Biochem. J 434 : 365 ~ 381 - [2011]
  • Prognostic marker for liver disease due to alpha1-antitrypsin deficiency
    Pferdmenges DC Klin Padiatr 225 : 257 ~ 262 - [2013]
  • Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B
    Myers RP J Hepatol 39 : 222 ~ 230 - [2003]
  • Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort
    Lok AS Hepatology 42 : 282 ~ 292 - [2005]
  • Noninvasive prediction of fibrosis in patients with chronic hepatitis C
    Thabut D Hepatology 37 : 1220 ~ 1221 - [2003]
  • Noninvasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C
    Cheong JY Dig Dis Sci 56 : 555 ~ 563 - [2011]
  • Nonalcoholic fatty liver disease: a feature of the metabolic syndrome
    Marchesini G Diabetes 50 : 1844 ~ 1850 - [2001]
  • Liver fibrosis -- from bench to bedside
    Friedman SL. J Hepatol 38 (Suppl 1) : S38 ~ S53 - [2003]
  • Liver biopsy
    Bravo AA N Engl J Med 344 : 495 ~ 500 - [2001]
  • Iron, hepcidin and the metal connection
    Loréal O Front Pharmacol 5 : 128 ~ [2014]
  • Iron metabolic disorder in chronic hepatitis C : Mechanisms and relevance to hepatocarcinogenesis
    Hino K J Gastroenterol Hepatol 28 : 93 ~ 98 - [2013]
  • Iron and hepatic carcinogenesis
    Tirnitz-Parker JE Crit Rev Oncog 18 : 391 ~ 407 - [2013]
  • Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin
    Fletcher LM. J Gastroenterol Hepatol 14 : 202 ~ 214 - [1999]
  • Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
    Forns X Hepatology 36 : 986 ~ 992 - [2002]
  • Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model
    Hui AY Am J Gastroenterol 100 : 616 ~ 623 - [2005]
  • Human plasma proteinase inhibitors
    Travis J Annu Rev Biochem 52 : 655 ~ 709 - [1983]
  • Disorders of iron metabolism
    Andrews NC. N Engl J Med 341 : 1986 ~ 1995 - [1999]
  • Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection
    Metwally MA Am J Gastroenterol 99 : 286 ~ 291 - [2004]
  • Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid
    Leroy V Am J Gastroenterol 99 : 271 ~ 279 - [2004]
  • Changes in serum proteinase inhibitor levels following bone surgery
    Dickson I Clin Chim Acta 54 : 381 ~ 385 - [1974]
  • Bleeding complications after percutaneous liver biopsy. An analysis of risk factors
    Terjung B Digestion 67 : 138 ~ 145 - [2003]
  • Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin
    Poynard T Hepatology 38 : 481 ~ 492 - [2003]
  • Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
    Imbert-Bismut F Lancet 357 : 1069 ~ 1075 - [2001]
  • Alpha1-antitrypsin deficiency
    Kohnlein T Internist (Berl) 51 (Suppl 1) : S269 ~ S276 [2010]
  • Alpha-1 antitrypsin is a potential biomarker for hepatitis B
    Tan XF Virol J 8 : 274 ~ - [2011]
  • Alcohol and iron: one glass of red or more?
    Fletcher LM. J Gastroenterol Hepatol 11 : 1039 ~ 1041 - [1996]
  • Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins
    Van Molle W J Immunol 163 : 5235 ~ 5241 [1999]
  • A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
    Wai CT Hepatology 38 : 518 ~ 526 - [2003]